Chronic inflammation has been well documented as a risk factor for cardiovascular diseases [34], and given that OPN is an established inflammatory mediator, it is plausible that this biomarker could play a crucial role in enhancing this risk. Here, SPP1 is linked to cardiovascular disorder.